News
-
-
REGULATED PRESS RELEASE
bioMérieux – First-Half 2026 Results
-
-
-
-
-
-
REGULATED PRESS RELEASE
bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE FILMARRAY Gastrointestinal Panels to enhance detection of gastrointestinal pathogens -
-
REGULATED PRESS RELEASE
Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
bioMérieux submits Dual 510(k)/CLIA Waiver application to FDA for BIOFIRE® SPOTFIRE® Vaginitis Panel, a rapid PCR test for women's health diagnostics at point of care
